The Iga Nephropathy Drugs Market continues to expand as the demand for targeted therapeutic interventions for the most common primary glomerulonephritis intensifies across nephrology clinics, academic medical centers, and pharmaceutical development pipelines worldwide. IgA nephropathy drugs encompass a growing portfolio of immunomodulatory, anti-inflammatory, and complement-targeting agents...